232 related articles for article (PubMed ID: 34108554)
21. Rotavirus-induced lncRNA SLC7A11-AS1 promotes ferroptosis by targeting cystine/glutamate antiporter xCT (SLC7A11) to facilitate virus infection.
Banerjee S; Sarkar R; Mukherjee A; Mitra S; Gope A; Chawla-Sarkar M
Virus Res; 2024 Jan; 339():199261. PubMed ID: 37923170
[TBL] [Abstract][Full Text] [Related]
22. Changes in glutamate and glutamine distributions in the retinas of cystine/glutamate antiporter knockout mice.
Knight LJ; Martis RM; Donaldson PJ; Acosta ML; Lim JC
Mol Vis; 2023; 29():274-288. PubMed ID: 38222448
[TBL] [Abstract][Full Text] [Related]
23. Identification, Expression, and Roles of the Cystine/Glutamate Antiporter in Ocular Tissues.
Martis RM; Knight LJ; Donaldson PJ; Lim JC
Oxid Med Cell Longev; 2020; 2020():4594606. PubMed ID: 32655769
[TBL] [Abstract][Full Text] [Related]
24. Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models.
Ruiu R; Cossu C; Iacoviello A; Conti L; Bolli E; Ponzone L; Magri J; Rumandla A; Calautti E; Cavallo F
J Exp Clin Cancer Res; 2023 Sep; 42(1):254. PubMed ID: 37770957
[TBL] [Abstract][Full Text] [Related]
25. Lipocalin 2 plays an immunomodulatory role and has detrimental effects after spinal cord injury.
Rathore KI; Berard JL; Redensek A; Chierzi S; Lopez-Vales R; Santos M; Akira S; David S
J Neurosci; 2011 Sep; 31(38):13412-9. PubMed ID: 21940434
[TBL] [Abstract][Full Text] [Related]
26. Dopaminergic neurons of system x(c)⁻-deficient mice are highly protected against 6-hydroxydopamine-induced toxicity.
Massie A; Schallier A; Kim SW; Fernando R; Kobayashi S; Beck H; De Bundel D; Vermoesen K; Bannai S; Smolders I; Conrad M; Plesnila N; Sato H; Michotte Y
FASEB J; 2011 Apr; 25(4):1359-69. PubMed ID: 21191088
[TBL] [Abstract][Full Text] [Related]
27. Slc7a11 (xCT) protein expression is not altered in the depressed brain and system xc- deficiency does not affect depression-associated behaviour in the corticosterone mouse model.
Demuyser T; Deneyer L; Bentea E; Albertini G; Femenia T; Walrave L; Sato H; Danbolt NC; De Bundel D; Michotte A; Lindskog M; Massie A; Smolders I
World J Biol Psychiatry; 2019 Jun; 20(5):381-392. PubMed ID: 28882088
[No Abstract] [Full Text] [Related]
28. Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target.
Albrecht P; Lewerenz J; Dittmer S; Noack R; Maher P; Methner A
CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):373-82. PubMed ID: 20053169
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of NOX2 signaling limits pain-related behavior and improves motor function in male mice after spinal cord injury: Participation of IL-10/miR-155 pathways.
Sabirzhanov B; Li Y; Coll-Miro M; Matyas JJ; He J; Kumar A; Ward N; Yu J; Faden AI; Wu J
Brain Behav Immun; 2019 Aug; 80():73-87. PubMed ID: 30807841
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of TRESK Channels Contributes to Motor and Sensory Recovery after Spinal Cord Injury.
Kim GT; Siregar AS; Kim EJ; Lee ES; Nyiramana MM; Woo MS; Hah YS; Han J; Kang D
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256222
[TBL] [Abstract][Full Text] [Related]
31. Cystine/glutamate antiporter blockage induces myelin degeneration.
Soria FN; Zabala A; Pampliega O; Palomino A; Miguelez C; Ugedo L; Sato H; Matute C; Domercq M
Glia; 2016 Aug; 64(8):1381-95. PubMed ID: 27247047
[TBL] [Abstract][Full Text] [Related]
32. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.
Koppula P; Zhang Y; Shi J; Li W; Gan B
J Biol Chem; 2017 Aug; 292(34):14240-14249. PubMed ID: 28630042
[TBL] [Abstract][Full Text] [Related]
33. Cystine/glutamate transporter, system x
Kobayashi S; Hamashima S; Homma T; Sato M; Kusumi R; Bannai S; Fujii J; Sato H
Nitric Oxide; 2018 Aug; 78():32-40. PubMed ID: 29792932
[TBL] [Abstract][Full Text] [Related]
34. Hyperexcitability and brain morphological differences in mice lacking the cystine/glutamate antiporter, system x
Sears SMS; Roberts SH; Hewett SJ
J Neurosci Res; 2021 Dec; 99(12):3339-3353. PubMed ID: 34747522
[TBL] [Abstract][Full Text] [Related]
35. Regulation of system x(c)(-)activity and expression in astrocytes by interleukin-1β: implications for hypoxic neuronal injury.
Jackman NA; Uliasz TF; Hewett JA; Hewett SJ
Glia; 2010 Nov; 58(15):1806-15. PubMed ID: 20645408
[TBL] [Abstract][Full Text] [Related]
36. xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain.
Ungard RG; Linher-Melville K; Nashed MG; Sharma M; Wen J; Singh G
Mol Pain; 2019; 15():1744806918822185. PubMed ID: 30799686
[TBL] [Abstract][Full Text] [Related]
37. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.
Hasegawa M; Takahashi H; Rajabi H; Alam M; Suzuki Y; Yin L; Tagde A; Maeda T; Hiraki M; Sukhatme VP; Kufe D
Oncotarget; 2016 Mar; 7(11):11756-69. PubMed ID: 26930718
[TBL] [Abstract][Full Text] [Related]
38. Mapping of the cystine-glutamate exchanger in the mouse eye: a role for xCT in controlling extracellular redox balance.
Martis RM; Donaldson PJ; Li B; Middleditch M; Kallingappa PK; Lim JC
Histochem Cell Biol; 2019 Oct; 152(4):293-310. PubMed ID: 31396687
[TBL] [Abstract][Full Text] [Related]
39. Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation.
Shih AY; Erb H; Sun X; Toda S; Kalivas PW; Murphy TH
J Neurosci; 2006 Oct; 26(41):10514-23. PubMed ID: 17035536
[TBL] [Abstract][Full Text] [Related]
40. Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells.
Linher-Melville K; Haftchenary S; Gunning P; Singh G
Mol Cell Biochem; 2015 Jul; 405(1-2):205-21. PubMed ID: 25896132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
